This week, pharmacy benefit manager (PBM) Express Scripts announced that both of the new PCSK9 inhibitors—Repatha (from Amgen) and Praluent (from Sanofi/Regeneron)—will be on its National Preferred Formulary. Both products will be subject to extensive prior authorization and step therapy. Show More Summary
When it comes to communications, the environment has been fast, the FDA – slow. A few months ago I talked about a few of the potentially game changing implications of some relatively new platforms – Meerkat and Periscope, which allow … Continue reading ?
I wasn't able to attend ExL's Digital Pharma East (DPE15) conference last week in Philly, so I assume no tough questions were asked. For example, nobody asked AstraZeneca if its @AZHelps Twitter account actually helps people. @AZHelps...Show More Summary
I gave the following presentation at a Bayer Pharma's STEM4Health Master Class Meetup in Berlin on 23 September 2015. Mastering Mobile Social Media to Improve Health Outcomes from Pharmaguy
I am pleased to announce the availability of our new report: the 2015-16 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. We’re offering special discounts if you order before October 24, 2015.This year’s report—our sixth edition—has been updated, revised, reorganized, and expanded. Show More Summary
Dear friend of AllTrials Over the past few weeks we've heard some great examples of what AllTrials supporters are doing to get all clinical trials registered and reported. Here’s what some of your fellow campaign supporters have been up to. Show More Summary
CBI’s 11th Life Sciences Trade and Channel StrategiesDecember 9-10, 2015 | Philadelphia, PAAre you ready for some drug channel strategy?Then join me at CBI’s 11th Trade and Channel Strategies conference, being held this December in Philadelphia. Show More Summary
Last August I wrote a posting about the important role of communications during the initial stages of an emerging contagious or communicable disease. But communications not only serves a vital purpose at the beginning of an epidemic, it also does … Continue reading ?
By Marcia Angell In 1953, a new drug was released by Burroughs Wellcome, a pharmaceutical company based in London. Pyrimethamine, as the compound was named, was originally intended to fight malaria after the microorganisms that cause the disease developed resistance to earlier therapies. Show More Summary
Joaquin is a knock knock knockin’ at our door. While the government did not shut down due to a political crisis, it may not be clear that a weather crisis won’t do the job. Washington can always use a good … Continue reading ?
The Centers for Medicaid & Medicare Services (CMS) just released data on 2016's Medicare Part D plans. Our exclusive, warp speed analysis reveals that 85% of Medicare Part D regional prescription drug plans (PDP) will have a preferred cost sharing network in 2016. Show More Summary
Rejoice, fans of medical billing codes. It’s ICD-10 Compliance Day! As you may know, the International Classification of Diseases (ICD) will expand the number of medical service codes for doctors and hospitals, from 18,000 in the ICD-9 to more than 140,000 in the ICD-10. Show More Summary
Editors-in-Chief Kasturi Haldar and Grant McFadden highlight 10 years of PLOS Pathogens research in celebration of past accomplishments and future endeavors. As PLOS Pathogens turns 10, we are excited to assemble a collection of primary research articles that reflects the … Continue reading » The post PLOS Pathogens at 10 Years appeared first on Speaking of Medicine.
Fall is here! Curl up with your extra hot grande Pumpkin Spice Whatever and check out this cornucopia of stories harvested from the Drug Channels crop: A neat profile of Helena Foulkes, president of CVS/pharmacy (and future CEO of CVS...Show More Summary
eyeforpharma Real World Evidence & Market Access Summit 2015December 3-4, 2015 | Philadelphia, PAwww.eyeforpharma.com/rwe/ The 4th annual eyeforpharma Real World Evidence & Market Access Summit 2015 provides attendees with 5 strategic events in one, offering a rare 360° view on how big data becomes evidence, and evidence becomes value. Show More Summary
On Tuesday, AmerisourceBergen announced a new $2.4 billion share repurchase program. Read the press release. This new program brings ABC’s total repurchases to more than $4 billion in less than two years. Here's why: ABC’s multi-faceted...Show More Summary